✦ LIBER ✦

Cognitive function in patients with alzheimer's dementia and concomitant cerebrovascular disease treated with galantamine - a one year open-label phase-IIIb-study

✍ Scribed by Ibach, B.; Gerwe, M.; Schwalen, S.; Riepe, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive effects of a prolonged-release

✍ Gerwe, M.; Ibach, B.; Czekalla, J.; Moeller, H.J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 44 KB

Disease progression in patients with mil

✍ Gaudig, Maren; Richarz, Ute; Rettig, Klaus; Djelani, Miriam; Schauble, Barbara 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A 6-month open-label study of the effect

✍ C.E. Patterson; A.P. Passmore; V.L.S. Crawford 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Efficacy study of galantamine in possibl

✍ N. Thavichachart; K. Phanthumchinda; S. Chankrachang; R. Praditsuwan; S. Nidhina 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Apathy in patients with mild cognitive i

✍ Philippe H. Robert; Claudine Berr; Magali Volteau; Christelle Bertogliati; Miche 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Gait Changes with Anti-Dementia Drugs: A

✍ O. Beauchet; C. P. Launay; G. Allali; F. R. Herrmann; C. Annweiler 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 389 KB